In situ assessment of the role of the β1-, β2- and β3-adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue

British Journal of Pharmacology

Volumn 117, Issue 5, 1996, Pages 907-913

  Barbe, Pierre ^a   Millet, Laurence ^a   Galitzky, Jean ^a   Lafontan, Max ^a   Berlan, Michel ^a  

^a INSERM   (France)

Author keywords

Blood flow; CGP 12,177; Dobutamine; Glycerol; Human subcutaneous adipose tissue; Isoprenaline; Lipolysis; Microdialysis; Terbutaline; 1 2 and 3 adrenoceptors

Indexed keywords

4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; ALCOHOL; BETA 1 ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 3 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; DOBUTAMINE; GLYCEROL; ISOPRENALINE; TERBUTALINE;

ADIPOSE TISSUE BLOOD FLOW; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; LIPOLYSIS; MALE; MICRODIALYSIS; NORMAL HUMAN; NUTRITION; PRIORITY JOURNAL; SUBCUTANEOUS FAT;

ADIPOSE TISSUE; ADRENERGIC BETA-AGONISTS; ADULT; CELLS, CULTURED; DOBUTAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOL; FEMALE; GLYCEROL; HUMANS; LIPOLYSIS; MALE; MICRODIALYSIS; PROPANOLAMINES; RECEPTORS, ADRENERGIC, BETA; TERBUTALINE;

EID: 0029670099     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15279.x     Document Type: Article

References (45)

1. ARNER, P. (1992). Adrenergic receptor function in fat cells. Am. J. Clin. Nutr., 55, 228S-236S.
2. ARNER, P., BOLINDER, J., ELIASSON, A., LUNBIND, A. & UNGERSTEDT, U. (1988). Microdialysis of adipose tissue and blood for in vivo lipolysis studies. Am. J. Physiol., 255, E737-E742.
3. 2-adrenoceptors regulate catecholamine tachyphylaxia in human adipose tissue. J. Pharmacol. Exp. Ther., 259, 317-322.
4. ARNER, P., KRIEGHOLM, E., ENGFELDT, P. & BOLINDER, J. (1990). Adrenergic regulation of lipolysis in situ at rest and during exercise. J. Clin. Invest., 85, 893-898.
5. BERLAN, M., GALITZKY, J., BOUSQUET-MELOU, A., LAFONTAN, M. & MONTASTRUC, J.L. (1994). Beta-3 Adrenoceptor-mediated increase in cutaneous blood flow in the dog. J. Pharmacol. Exp. Ther., 268, 1444-1451.
6. BERNST, E. & GUTMAN, I. (1974). Determination of ethanol with alcohol dehydrogenase and NAD. In Methods of Enzymatic Analysis. ed. Bergmeyer, H.U. Vol. 3 pp. 1499-1505. Verlag, Weinheim. New York, San Francisco, London: Academic Press Inc.
7. BOUSQUET-MELOU, A., GALITZKY, J., CARPENE, C., BERLAN, M. & LAFONTAN, M. (1994). β-Adrenergic control of lipolysis in primate white fat cells: a comparative study with nonprimate mammals. Am. J. Physiol., 267, R115-R123.
8. BOUSQUET-MELOU, A., GALITZKY, J., MUNOZ, C.M., BERLAN, M. & LAFONTAN, M. (1995). Desensitization of β-adrenergic responses in adipocytes involves receptor subtypes and cyclic AMP phosphodiesterase. Eur. J. Pharmacol.-Mol. Pharmacol. Sect., 289, 235-247.
9. BRADLEY, D.C. & KASLOW, H.R. (1989). Radiometric assays for glycerol, glucose and glycogen. Anal. Biochem., 180, 11-16.
10. 2-adrencrgic one. Am. J. Physiol., 265, E74-E80.
11. COPPACK, S.W., JENSEN, M.D. & MILES, J.M. (1994). In vivo regulation of lipolysis in humans. J. Lipid Res., 35, 177-93.
12. DOLAN, J.A., MUENKEL, H.A., BURNS, M.G., PELLEGRINO, S.M., ERASER, C.M., PIETRI, F., STROSBERG, D.A., LARGIS, E.E., DUTIA, M.D., BLOOD, J.D., BASS, A.S., TAKINELLA, T.K., COBUZZI, A. LAI, F.M. & CLAUS, T.H. (1994). Beta-3 adrenoceptor selectivity of the dioxolane dicarboxylate phenethanolamines. J. Pharmacol. Exp. Ther., 269, 1000-1006.
13. DURNIN, J.V.G. & WOMERSLEY, J. (1974). Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 418 men and women aged from 16 to 72 years. Br. J. Nutr., 32, 77-97.
14. ENOCKSSON, S., SHIMIZU, M., LÖNNQVIST, F., NORDENSTRÖM, J. & ARNER, P. (1995). Demonstration of an in vivo functional β3-adrenoceptor in man. J Clin. Invest., 95, 2239-2245.
15. GALITZKY, J., LAFONTAN, M., NORDENSTRÖM, J. & ARNER, P. (1993). Role of vascular alpha2-adrenoceptors in regulating lipid mobilization from human adipose tissue. J. Clin. Invest., 91, 1997-2003.
16. GIACOBINO, J.P. (1995). β-3 Adrenoceptor: an update. Eur. J. Endocrinol., 132, 377-385.
17. GRANNEMAN, J.G., LAHNERS, K.N. & RAO, D.D. (1992). Rodent and human beta3-adrenergic receptor genes contain an intron within the protein-coding block. Mol. Pharmacol., 42, 964-970.
18. HELLMER, J., MARCUS, C., SONNENFELD, T. & ARNER, P. (1992). Mechanism for differences in lipolysis between human subcutaneous and omental fat cells. J. Clin. Endocr. Metab., 75, 15-20.
19. 133Xe clearance. Clin. Sci., 86, 15-25.
20. HICKNER, R.C., ROSDAHL, H., BORG, L. UNGERSTEDT, U., JORFELDT, L. & HENRIKSSON, J. (1991). Ethanol may be used with the microdialysis technique to monitor blood flow changes in skeletal muscle: dialysate glucose concentration is blood flow-dependent. Acta Physiol. Scand., 143, 355-356.
21. HOLLENGA, C., HAAS, M., DEINUM, J.T. & ZAAGSMA, J. (1990). Discrepancies in lipolytic activities induced by beta-adrenoceptor agonists in human and rat adipocytes. Horm. Metab. Res., 22, 17-21.
22. JANSSON, P.A., FOWELIN, J., SMITH, U. & LÖNNROTH, P. (1988). Characterization by microdialysis of intercellular glucose levels in subcutaneous tissue in humans. Am. J. Physiol., 255, E218-E220.
23. JANSSON, P.-A., LARSSON, A., SMITH, U. & LÖNNROTH, P. (1992). Glycerol production in subcutaneous adipose tissue of lean and obese humans. J. Clin. Invest., 89, 1610-1617.
24. JANSSON, P.A., SMITH, U. & LÖNNROTH, P. (1990). Interstitial glycerol concentration measured by microdialysis in two subcutaneous regions in humans. Am. J. Physiol., 258, E918-E922.
25. KRIEF, S., LÖNNQVIST, F., RAIMBAULT, S., BAUDE, B., SPRONSEN, A.V., ARNER, P., STROSBERG, A.D., RICQUIER, D. & EMORINE, L.J. (1993). Tissue distribution of beta3-adrenergic receptor mRNA in man. J. Clin. Invest., 91, 344-349.
26. LAFONTAN, M. (1994). Differential recruitment and differential regulation by physiological amines of fat cell β1-, β2- and β3-adrenergic receptors expressed in native fat cells and in transfected cell lines. Cell. Signalling, 6, 363-392.
27. LAFONTAN, M. & BERLAN, M. (1993). Fat cell adrenergic receptors and the control of white and brown fat cell function. J. Lipid. Res., 34, 1057-1091.
28. LANDS, A.M., ARNOLD, A.M., MCAULIFF, J.P. & LUDUENA, F.P. (1967). Differentiation of receptor systems activated by sympathomimetic amines. Nature, 214, 597-598.
29. LANGIN, D., PORTILLO, M., SAULNIER-BLACHE, J.-S. & LAFONTAN, M. (1991). Coexistence of three beta-adrenergic receptor subtypes in white fat cells of various mammalian species. Eur. J. Pharmacol., 199, 291-301.
30. LINDE, B., HJELMDAHL, P., FREYSCHUSS, U. & JUHLIN-DANNFELT, A. (1981). Adipose tissue and skeletal muscle blood flow during mental stress. Am. J. Physiol., 256, E12-E18.
31. LÖNNQVIST, F., KRIEF, S., STROSBERG, A.D. NYBERG, B., EMORINE, L.J. & ARNER, P. (1993). Evidence for a functional beta3-adrenoceptor in man. Br. J. Pharmacol., 110, 929-936.
32. LÖNNQVIST, F., THÖRNE, A., NILSELL, K., HOFFSTEDT, J. & ARNER, P. (1995). A pathogenic role of visceral fat β3-adrenoceptor in obesity. J. Clin. Invest., 95, 1109-1116.
33. LÖNNROTH, P., JANSSON, P.A. & SMITH, U. (1987). A microdialysis method allowing characterization of intracellular waterspace in humans. Am. J. Physiol., 253, E228-E231.
34. MAURIEGE, P., MARETTE, A., ATGIE, C., BOUCHARD, C., THERIAULT, G., BUKOWIECKI, L.K., MARCEAU, P., BIRON, S., NADEAU, A. & DESPRES, J.-P. (1995). Regional variation in adipose tissue metabolism of severely obese premenopausal women. J. Lipid Res., 36, 672-684.
35. 11CGP-12177 to assess β-adrenergic receptor concentration in idiopathic dilated cardiomyopathy. Circulation, 87, 1160-1178.
36. 3H]CGP12177, generally classified as an antagonist, is a thermogenic agonist in brown adipose tissue. Biochem. J., 261, 401-405.
37. REVELLI, J.P., MUZZIN, P., PAOLONI, A., MOINAT, M. & GIACOBINO, J.-P. (1993). Expression of the beta3-adrenergic receptor in human white adipose tissue. J. Mol. Endocrinol., 10, 193-197.
38. RODBELL, M. (1964). Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis. J. Biol. Chem., 239, 375-380.
39. ROSELL, S. & BELFRAGE, E. (1979). Blood circulation in adipose tissue. Physiol. Rev., 59, 1078-1104.
40. ROSENBAUM, M., MALBON, C.C., HIRSCH, J. & LEIBEL, R.L. (1993). Lack of beta3-adrenergic effect on lipolysis in human subcutaneous adipose tissue. J. Clin. Endocrinol. Metab., 77, 352-355.
41. SHEN, Y.-T., ZHANG, H. & VATNER, S.F. (1994). Peripheral vascular effects of beta3-adrenergic receptor stimulation in conscious dogs. J. Pharmacol. Exp. Ther., 268, 466-473.
42. STAHLE, L., SEVERSVÄRD, S. & UNGERSTEDT, U. (1991). A comparison between three methods for estimation of extracellular concentrations of exogenous and endogenous compounds by microdialysis. J. Pharmacol. Methods., 25, 41-52.
43. THOMAS, R.F. & LIGGETT, S.B (1993). Lack of beta3-adrenergic receptor mRNA expression in adipose and other metabolic tissues in the adult human. Mol. Pharmacol., 43, 343-348.
44. VAN LIEFDE, I., ERMEN, A.V. & VAUQUELIN, G. (1994). No functional atypical β-adrenergic receptors in human omental adipocytes. Life Sci., 54, 209-214.
45. ZAAGSMA, J. & NAHORSKI, S.R. (1990). Is the adipocyte beta-adrenoceptor a prototype for the recently cloned atypical 'beta3-adrenoceptor'? Trends Pharmacol. Sci., 11, 3-7.